The United States Angina Pectoris Drugs Market is supported by substantial healthcare spending, a significant burden of coronary artery disease, and widespread access to cardiovascular diagnosis and treatment services. The increasing use of antianginal medications, including beta-blockers, calcium channel blockers, nitrates, and other therapeutic agents, is contributing to improved disease...